Enigma of the high prevalence of anti-SARS-CoV-2 antibodies in HIV-positive people with no symptoms of COVID-19 in Burkina Faso

The severe acute respiratory syndrome due to the new coronavirus (SARS-CoV-2), responsible for coronavirus disease (COVID-19), has severely tested the global health response capacity, with predictions of a fatality for developing countries. To evaluate the prevalence of anti-SARS-CoV- 2 antibodies i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagna, Tani, Ouedraogo, Paul, Traore, Lassina, Obiri-Yeboah, Dorcas, Yonli, Albert, Tapsoba, Aristide, Tovo, Frida, Sorgho, Abel, Zongo, Laetitia, Nikiema, Ouégo, Ilboudo, Dénise, Belemgnegre, Marius, Nadembega, Christelle W., Ouermi, Djeneba, Djigma, Florencia W., Zohoncon, Théodora M., Poaty, Henriette, Colizzi, Vittorio, Simpore, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202456/
https://www.ncbi.nlm.nih.gov/pubmed/35720802
http://dx.doi.org/10.4081/jphia.2022.1778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202456/
https://www.ncbi.nlm.nih.gov/pubmed/35720802
http://dx.doi.org/10.4081/jphia.2022.1778

Ejemplares similares